Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0428
+0.0010 (2.34%)
At close: Feb 27, 2026
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $1.79 million as of February 27, 2026. Its market cap has decreased by -90.68% in one year.
Market Cap
1.79M
Enterprise Value
-224.87K
Revenue
52.63M
Ranking
n/a
PE Ratio
0.22
Stock Price
$0.04
Market Cap Chart
Since March 8, 2023, Carisma Therapeutics's market cap has decreased from 147.73M to 1.79M, a decrease of -98.79%. That is a compound annual growth rate of -77.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.79M | -0.51% |
| Dec 31, 2025 | 1.80M | -89.71% |
| Dec 31, 2024 | 17.48M | -85.21% |
| Dec 29, 2023 | 118.25M | -19.96% |
| Mar 8, 2023 | 147.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaccinex | 2.76M |
| Clearside Biomedical | 2.67M |
| LakeShore Biopharma | 2.65M |
| VitaSpring Biomedical | 2.30M |
| ZyVersa Therapeutics | 2.10M |
| Agentix | 2.00M |
| Neon Bloom | 1.85M |
| Exousia Pro | 1.81M |